DEBORAH BARON
Board of Directors member
Deborah Baron is Senior Vice President, Worldwide Business Development for Pfizer Inc. In this role, Debbie leads all Pfizer business development activities including prioritizing opportunities, conducting evaluations, and executing transactions. She and her team manage a wide range of transaction types including venture investments, research/development/commercial collaborations, license agreements, mergers and acquisitions, and divestitures.
Debbie recently served on the board of directors at Cerevel Therapeutics (recently acquired by AbbVie, Inc.). As a Pfizer representative, Debbie has also previously been on the board of the Pfizer-GSK Consumer Healthcare Joint Venture.
Prior to her present role, Debbie held positions of increasing responsibility at Pfizer, including leading business development activities in Pfizer’s Primary Care and Emerging Markets businesses. Before joining Pfizer in 2002, Debbie was an Associate Principal in the New York office of McKinsey and Company, a management consulting firm, and previously she worked as a manufacturing engineer at The Stanley Works in New Britain, Connecticut.
Debbie received an M.B.A. from the MIT Sloan School of Management and a B.S. in mechanical engineering from MIT.
YOU MAY ALSO BE INTERESTED IN
Together we are engaged in the HIV response throughout the world, supported by a team of over 1,100 dedicated ViiV Healthcare staff working across the globe.
Discover more about who we are, the work we do and what we're doing to advance HIV science, support the delivery of HIV treatment and care; and work with partners to address the stigma and discrimination faced by people living with HIV.
NP-GBL-HVX-COCO-220025 November 2024
If you get any side effects, talk to your doctor, pharmacist, or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the GSK Reporting Tool link https://gsk.public.reportum.com/. By reporting side effects, you can help provide more information on the safety of this medicine.
If you are from outside the UK, you can report adverse events to GSK/ ViiV by selecting your region and market, here.
